Navigation Links
NWBT Highlights Cost Effectiveness of DCVax® in View of Recent Immunotherapy Pricing Concerns
Date:8/10/2011

), the most aggressive and lethal form of brain cancer.  The Company also previously received clearance from the FDA for a 612-patient Phase III trial in prostate cancer, and clearance from the FDA for Phase I trials in five other cancers.  The Company has also conducted a Phase I/II trial with DCVax® for recurrent metastatic ovarian cancer.  For further information about clinical sites and/or about the Company, please visit the Company's web site at www.nwbio.com.

Disclaimer

Statements made in this news release that are not historical facts, including statements concerning future treatment of patients with GBM using DCVax®-Brain and future clinical trials, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Words such as "expects," "believes," "intends," and similar expressions are intended to identify forward-looking statements.  Actual results may differ materially from those projected in any forward-looking statement.  Specifically, there are a number of important factors that could cause actual results to differ materially from those anticipated, such as the Company's ability to raise additional capital, risks related to the Company's ability to enroll patients in its clinical trials and

complete the trials on a timely basis, the uncertainty of the clinical trials process, uncertainties about the timely performance of third parties, and whether the Company's products will demonstrate safety and efficacy.  Additional information on these and other factors, including Risk Factors, which could affect the Company's results, is included in its Securities and Exchange Commission ("SEC") filings.  Finally, there may be other factors not mentioned above or included in the Company's SEC filings that may cause actual results to differ materially from those projected in any forward-looking state
'/>"/>

SOURCE Northwest Biotherapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment
2. CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results
3. Isis Reports Financial Results and Highlights for Second Quarter 2011
4. Bionovo Announces Second Quarter 2011 Highlights and Financial Results
5. Thomas Publishing Expands Brand Information and Highlights Its Career Center on a New Company Website
6. Novartis highlights extensive data on numerous compounds at ASCO in multiple cancers, including Phase III studies in GIST and myelofibrosis
7. Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches
8. Hospira Highlights Progress in 2010 at Its 2011 Annual Meeting of Shareholders
9. Data Presented at Digestive Disease Week Highlights Additional Analysis of DIFICID™ Phase 3 Data
10. Isis Reports Financial Results and Highlights for First Quarter 2011
11. Anadys Pharmaceuticals Reports First Quarter 2011 Financial Results and Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... , March 6, 2015 ... validation from Intuitive Surgical, the manufacturer of ... Triton-36 Instrument Cleaning System. This approval reflects the ... in cleanliness currently in place for the sterile ... validation for reprocessing robotic surgical instruments for re-use. ...
(Date:3/6/2015)... R.I. , March 6, 2015 Troyen ... Medical Officer of CVS Health (NYSE: CVS ... Health in Washington, D.C. today. ... critical role in addressing health care cost and quality ... After making CVS/pharmacy the first national pharmacy chain to ...
(Date:3/6/2015)... WILMINGTON, Del. , March 6, 2015 /PRNewswire/ ... Patent and Trademark Office,s publication of U.S. Patent ... Eating Disorder."  The ,249 Patent Application features claimed methods ... may be used to treat Binge Eating Disorder ... "information material," or "flyer or an advertisement," as ...
Breaking Medicine Technology:Ultra Clean Systems Reaches Exclusive Place within Robotic Surgical Instrument Cleaning Industry with Latest Certifications 2CVS Health Chief Medical Officer to Address National Business Group on Health on Value of Pharmacy Care in Evolving Health Care System 2CVS Health Chief Medical Officer to Address National Business Group on Health on Value of Pharmacy Care in Evolving Health Care System 3Lucerne Biosciences Announces Publication of Claimed Methods for Treating Binge Eating Disorder with Lisdexamfetamine Dimesylate 2
... 2011 As the nation seeks to expand ... burdensome costs, researchers from Harvard University, Brigham and ... CVS ) reported that preventative health care may ... to expanded use of cost-effective generic medications for ...
... WOODCLIFF LAKE, N.J., July 6, 2011 Par Pharmaceutical Companies, ... will host a conference call and live webcast on Wednesday, ... for the second quarter 2011. The Company will release its ... Access to the live webcast can be made ...
Cached Medicine Technology:CVS Caremark, Harvard and Brigham and Women's Research Shows Generic Medications are Changing the Economics of Treating Chronically Ill Patients 2CVS Caremark, Harvard and Brigham and Women's Research Shows Generic Medications are Changing the Economics of Treating Chronically Ill Patients 3CVS Caremark, Harvard and Brigham and Women's Research Shows Generic Medications are Changing the Economics of Treating Chronically Ill Patients 4
(Date:3/6/2015)... 06, 2015 Ticket Down is a reputable ... at the Moda Center. After being away from ... is showing no signs of letting up on his “Garth ... and his wife, Trisha Yearwood, to venues around the United ... their critically acclaimed tour to the Moda Center in Portland, ...
(Date:3/6/2015)... As the Muscular Dystrophy Association continues to enhance its ... two new Scientific Program Officers, Amanda Haidet-Phillips, Ph.D and ... Pavlath, Ph.D, who joined MDA late last year as ... will lead MDA as it accelerates new front-line discovery ... of neuromuscular and motor neuron diseases. , ...
(Date:3/6/2015)... CA (PRWEB) March 06, 2015 US ... of three Maryland camps – two non-contact specialty camps ... be run by Perfect Performance Training, located at Bowie ... focus on developing position specific skills, speed and strength ... hosted at Salisbury University with Marvin Graves, former quarterback ...
(Date:3/6/2015)... Bakersfield, California (PRWEB) March 06, 2015 ... $5.7 million jury verdict on March 5, 2015 in ... County. According to court documents, a jury of 12 ... she suffered from being implanted with an Ethicon TVT ... of nine men and three women also awarded $5 ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 Jvion, ... the release of a Clostridium Difficile (C Diff) ... The C Diff use case is the latest ... span hospital acquired infections, chronic conditions, and individual ... the C Diff solution flags at risk individuals ...
Breaking Medicine News(10 mins):Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 2Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 4Health News:US Sports Camps to Host Three New Football Camps in Maryland 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Jvion Predicts Patients at Risk of C Difficile Infection to Reduce Risk and Save Lives 2
... that absorbs blue light has been linked to sleep disorders in ... 1 issue of the journal Sleep . As this type ... insomnia. "The strong link between lens yellowing and age could ... said Line Kessel, M.D., Ph.D., the study,s lead author. In ...
... of the speech information rate of seven languages concludes ... which languages are spoken, but much less variation in ... "A cross-linguistic perspective on speech information rate," to be ... journal Language , is co-authored by Franois Pellegrino, ...
... HealthDay Reporter , WEDNESDAY, Aug. 31 (HealthDay ... records instead of paper files could greatly improve care ... "did better and improved faster" at various kinds of ... author Dr. Randall D. Cebul, a professor of medicine ...
... WEDNESDAY, Aug. 31 (HealthDay News) -- Some breast cancer patients ... can skip hormone therapy without increasing their risk of death, ... had tumors that were hormone-receptor positive, which means they require ... tumors is designed to starve the breast cancer cells by ...
... modified a toxic chemical produced by tiny marine microbes and ... Writing today in ACS Medicinal Chemistry Letters , UF ... of marine cyanobacteria and made it more specifically toxic ... of the compound to mice with a form of colon ...
... an easy way to improve your health: trust your neighbors. ... that increasing trust in neighbors is associated with better self-reported ... where one fits into the income distribution in their local ... self-rated health," said Eileen Bjornstrom, an assistant professor of sociology ...
Cached Medicine News:Health News:Aging eyes linked to sleepless nights, new study shows 2Health News:Language speed versus efficiency: Is faster better? 2Health News:Electronic Medical Records Might Boost Diabetes Care 2Health News:Electronic Medical Records Might Boost Diabetes Care 3Health News:Some Older Breast Cancer Patients Can Skip Hormone Therapy: Study 2Health News:Some Older Breast Cancer Patients Can Skip Hormone Therapy: Study 3Health News:UF medicinal chemists modify sea bacteria byproduct for use as potential cancer drug 2Health News:UF medicinal chemists modify sea bacteria byproduct for use as potential cancer drug 3Health News:Trust in your neighbors could benefit your health, MU study shows 2
... Rusch Snap-Light™ laryngoscope blades are designed with ... fiber optic bundle can be removed to ... to reach areas. Our unique snap-on mechanism ... bright focused blades are interchangeable with other ...
... high quality fiberoptic system designed to meet ... fiberoptic laryngoscopes. The green color coding identifies ... to interconnect with other green coded systems. ... bright and focused light. The Greenspec pivot ...
Rigid plastic. Single use. Non-Sterile. The disposable laryngoscope blade that fits on a standard handle. Made of extremely rigid plastic. Bright white light out-performs metal blades. Single patient...
... Laryngoscopes are a high quality fiberoptic system ... greater standardization to fiberoptic laryngoscopes. The green ... indicates it's ability to interconnect with other ... offers a cool, bright and focused light. ...
Medicine Products: